19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2523
HELPLINE: 1-877-530-0002



SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace.

SCAMHC serves all individuals regardless of inability to pay. Discounts for essential services are offered based on family size and income. For more information, contact (334) 222-2523 or our 24/7 Helpline at 1-877-530-0002.



powered by centersite dot net
Basic InformationLatest News
Cigarette Sales Jumped During PandemicSwitch to Vaping Won't Help Ex-Smokers Quit for Good: StudyFDA Authorizes First E-CigaretteSilver Lining Found in Pandemic: Fewer Teens Are VapingSmoking, Drinking Gateway to Pot, Study FindsDelay in Graphic Warning Labels on Cigarettes Cost Lives: StudyPfizer Recalls All Lots of Anti-Smoking Drug Chantix Due to Potential CarcinogenIs There a Link Between Vaping and Eating Disorders in the Young?FDA Bans Sale of Nearly a Million E-Cigarettes; Allows Juul to Remain on MarketVaping Raises Blood Clotting Risks, Harms Small Arteries: StudyFDA Tells Three Small E-Cigarette Makers to Stop Selling Flavored ProductsWomen May Find It Tougher to Quit Smoking Than MenKids Who Grew Up With Smokers Have Higher Odds for Rheumatoid ArthritisVaping Just Once Triggers Dangerous 'Oxidative Stress'Gruesome Cigarette Warnings May Work on Smokers: StudyBrain 'Zap' Treatment Might Curb SmokingAddictive, Harmful Vaping Is Super Cool on TikTokVaping During Pregnancy Could Raise Odds for 'Preemie' BabiesAHA News: Smoking Harms the Brain, Raises Dementia Risk – But Not If You QuitJuul to Pay $40 Million in N.C. Case Over Vaping's Harm to TeensSmokers, Obese People Need Major Heart Interventions Earlier in LifeDid People Smoke More or Less During the Pandemic?Many Heart Disease Patients Keep Smoking, Despite Knowing RisksYouth Vaping Rates Decline, But 1 in 5 U.S. Teens Still Uses E-CigsAHA News: Deep Disparities Persist in Who Gets Exposed to Secondhand SmokeDid a Ban on Flavored Vapes Raise Teen Smoking Rates?Vaping Ups Teens' Odds for Asthma, Asthma AttacksBreathing Other People's Smoke Can Raise Your Odds for Heart FailureFDA Poised to Ban Menthol CigarettesAHA News: Higher Pulse Pressure in Smokers May Signal Cardiovascular Disease RiskSecondhand Smoke Can Raise Odds for Mouth, Throat CancersAdding Vaping to Smoking Brings Even Worse Respiratory EffectsRaising Legal Age for Tobacco Cuts Teen Smoking, Study Confirms'Garage Lab' Vape Products May Be Driving Lung Injury in Rural AppalachiaA Plus From the Pandemic: Fewer Kids Using E-CigarettesMaking E-Cigs Cool: Singers, Models in Music Videos Get Teens VapingCanada's Menthol Cigarette Ban Boosted Quit Rates: Would the Same Happen in U.S.?Most U.S. Adults Who Vape Want to Quit: StudyBored & Stressed, Smokers Smoked More  During PandemicSecondhand Smoke Is Sending Kids to the ERSmoking Rates High Among Surgery PatientsSwitch to Vaping Helps Smokers With Schizophrenia QuitSmoking Makes a Comeback in the PandemicCOVID Lockdowns Got People Smoking MoreMenthols Lured 10 Million Americans to Smoking Since 1980: StudyAnother Deadly Disease for Smokers: Pulmonary FibrosisHow Smoking Could Help Spur Breast Cancer's SpreadAHA News: Anxiety Is Linked With Smoking – But How Is Still HazySmoking Raises Risk for Deadly 'Bleeding Strokes'Youth Vaping Triples Odds for Adult Smoking
Questions and AnswersVideosLinksBook Reviews
Related Topics

Wellness and Personal Development

Pfizer Recalls All Lots of Anti-Smoking Drug Chantix Due to Potential Carcinogen

HealthDay News
by Steven Reinberg
Updated: Sep 17th 2021

new article illustration

FRIDAY, Sept. 17, 2021 (HealthDay News) -- Pfizer is expanding the recall of its anti-smoking drug Chantix (varenicline), the company announced Friday.

The nationwide recall of all Chantix 0.5 mg and 1 mg tablets was prompted because they may contain levels of a nitrosamine, N-nitroso-varenicline, that are at or above levels approved by the U.S. Food and Drug Administration.

Long-term ingestion of N-nitroso-varenicline may be linked to a "theoretical potential increased cancer risk in humans," the company said, adding that no immediate risk to patients taking Chantix exists.

"The health benefits of stopping smoking outweigh the theoretical potential cancer risk from the nitrosamine impurity in varenicline," Pfizer said in its statement.

Nitrosamines are common in water and foods — including cured and grilled meats, dairy products and vegetables — so everyone is exposed to some level of these chemicals.

Patients taking Chantix should consult with their doctor about other treatment options. So far, Pfizer has received no reports of adverse events tied to this recall, the company stated.

More information

For more on the Chantix recall, visit the U.S. Food and Drug Administration.

SOURCE: Pfizer, news release, Sept. 17, 2021